These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8122713)
21. Fluoride therapy for cochlear otosclerosis? an audiometric and computerized tomography evaluation. Derks W; De Groot JA; Raymakers JA; Veldman JE Acta Otolaryngol; 2001 Jan; 121(2):174-7. PubMed ID: 11349772 [TBL] [Abstract][Full Text] [Related]
22. Histologically proven cochlear otosclerosis with pure sensorineural hearing loss. Balle V; Linthicum FH Ann Otol Rhinol Laryngol; 1984; 93(2 Pt 1):105-11. PubMed ID: 6712083 [TBL] [Abstract][Full Text] [Related]
23. Otospongiosis begins to yield its secrets. Gunby P JAMA; 1979 Oct; 242(15):1594, 1598-600. PubMed ID: 480570 [No Abstract] [Full Text] [Related]
24. Medical Management of Otosclerosis. de Oliveira Penido N; de Oliveira Vicente A Otolaryngol Clin North Am; 2018 Apr; 51(2):441-452. PubMed ID: 29502728 [TBL] [Abstract][Full Text] [Related]
25. Effect of sodium fluoride on early stages of otosclerosis. Colletti V; Fiorino FG Am J Otol; 1991 May; 12(3):195-8. PubMed ID: 1882968 [TBL] [Abstract][Full Text] [Related]
26. [Status of hearing in patients with otosclerosis shortly after conservative therapy with sodium fluoride]. Galochkin VI Vestn Otorinolaringol; 1986; (4):34-8. PubMed ID: 3750615 [No Abstract] [Full Text] [Related]
30. Medical therapy of otospongiosis. Shambaugh GE Acta Otorhinolaryngol Belg; 1981; 35(5-6):390-403. PubMed ID: 7347082 [No Abstract] [Full Text] [Related]
31. Further experiences with moderate dosage sodium fluoride for sensorineural hearing loss, tinnitus and vertigo due to otospongiosis. Shambaugh GE Adv Otorhinolaryngol; 1977; 22():35-42. PubMed ID: 868707 [No Abstract] [Full Text] [Related]
32. [Pathophysiology and treatment of otosclerosis. Use of sodium fluoride therapy]. Ivanović A; Mitrović M Vojnosanit Pregl; 1982; 39(2):95-9. PubMed ID: 7113022 [No Abstract] [Full Text] [Related]
33. Otosclerosis 1981 to 1985. Our four-year review and current perspective. Wiet RJ; Raslan W; Shambaugh GE Am J Otol; 1986 May; 7(3):221-8. PubMed ID: 3521305 [No Abstract] [Full Text] [Related]
34. Modification with NaF in disequilibrium of otospongiotic origin. Bretlau P; Causse JB; Causse J Adv Otorhinolaryngol; 1982; 28():73-9. PubMed ID: 7113821 [No Abstract] [Full Text] [Related]
36. Complications of the fenestration operation and their management. Shambaugh GE Otolaryngol Clin North Am; 1982 Nov; 15(4):837-43. PubMed ID: 7162821 [No Abstract] [Full Text] [Related]
40. [What may be expected from the therapy of otosclerosis using sodium fluoride?]. Chládek V; Slaninová B Cesk Otolaryngol; 1977 Oct; 26(5):267-71. PubMed ID: 603948 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]